CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $39,368
- in 1 filing
Net +$960,625. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-05-18 | Clark Mitchall G. EVP & Chief R & QA Officer | Sale | −25,860 | $50.03 | $1.3M | 107,972 |
| 2018-05-16 | Clark Mitchall G. EVP & Chief R & QA Officer | Sale | −4,347 | $46.04 | $200K | 134,132 |
| 2018-05-16 | Clark Mitchall G. EVP & Chief R & QA Officer | Sale | −300 | $46.30 | $14K | 133,832 |
| 2018-05-15 | Clark Mitchall G. EVP & Chief R & QA Officer | Exercise or conversion | +4,808 | 138,479 | ||
| 2018-05-15 | Clark Mitchall G. EVP & Chief R & QA Officer | Exercise or conversion · Restricted Stock Units | −4,808 | 0 | ||
| 2018-03-29 | Clark Mitchall G. EVP & Chief R & QA Officer | Sale | −22,400 | $40.07 | $898K | 133,671 |
| 2018-03-27 | Clark Mitchall G. EVP & Chief R & QA Officer | Exercise or conversion | +28,848 | $25.15 | $726K | 212,368 |
| 2018-03-27 | Clark Mitchall G. EVP & Chief R & QA Officer | Exercise or conversion | +32,500 | $22.72 | $738K | 244,868 |
| 2018-03-27 | Clark Mitchall G. EVP & Chief R & QA Officer | Exercise or conversion | +11,406 | $11.00 | $125K | 256,274 |
| 2018-03-27 | Clark Mitchall G. EVP & Chief R & QA Officer | Sale | −22,794 | $36.43 | $830K | 233,480 |
| 2018-03-27 | Clark Mitchall G. EVP & Chief R & QA Officer | Sale | −31,356 | $37.10 | $1.2M | 202,124 |
| 2018-03-27 | Clark Mitchall G. EVP & Chief R & QA Officer | Sale | −29,980 | $38.23 | $1.1M | 172,144 |
| 2018-03-27 | Clark Mitchall G. EVP & Chief R & QA Officer | Sale | −2,170 | $39.53 | $86K | 169,974 |
| 2018-03-27 | Clark Mitchall G. EVP & Chief R & QA Officer | Sale | −2,800 | $40.40 | $113K | 167,174 |
| 2018-03-27 | Clark Mitchall G. EVP & Chief R & QA Officer | Sale | −11,103 | $41.10 | $456K | 156,071 |
| 2018-03-27 | Clark Mitchall G. EVP & Chief R & QA Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −28,848 | 11,194 | ||
| 2018-03-27 | Clark Mitchall G. EVP & Chief R & QA Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −32,500 | 32,500 | ||
| 2018-03-27 | Clark Mitchall G. EVP & Chief R & QA Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −11,406 | 3,125 | ||
| 2018-02-15 | Clark Mitchall G. EVP & Chief R & QA Officer | Exercise or conversion | +7,211 | 187,124 | ||
| 2018-02-15 | Clark Mitchall G. EVP & Chief R & QA Officer | Shares withheld for taxes | −3,604 | $47.05 | $170K | 183,520 |
Page 1 of 3 · 50 trades